Vertex Pharmaceuticals Inc. buy UBS Group AG
Start price
05.11.24
/
50%
€459.85
Target price
05.11.25
€536.01
Performance (%)
-31.01%
Price
14:34
€317.25
Summary
This prediction is currently active. The BUY prediction by UBS_Group_AG for Vertex Pharmaceuticals Inc. is performing very badly with a performance of -31.01%. This prediction currently runs until 05.11.25. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Vertex Pharmaceuticals Inc. | -21.217% | -21.217% |
| iShares Core DAX® | 3.109% | -1.011% |
| iShares Nasdaq 100 | 3.088% | 3.918% |
| iShares Nikkei 225® | 4.760% | 5.119% |
| iShares S&P 500 | 1.840% | 2.235% |
Comments by UBS_Group_AG for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target raised by analysts at UBS Group AG from $562.00 to $586.00. They now have a "buy" rating on the stock.
Ratings data for VRTX provided by MarketBeat
Stopped prediction by UBS_Group_AG for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€344.35
05.08.25
05.08.25
€478.40
05.08.26
05.08.26
-7.87%
14:34
14:34
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€459.95
17.10.24
17.10.24
€519.06
17.10.25
17.10.25
-31.03%
14:34
14:34